Combined Therapeutics Granted Patent for its mRNA Vaccine Platform by USPTO

BOSTON, March 13, 2023 /PRNewswire/ — Combined Therapeutics Inc. (CTx) today announced its intellectual property position reinforcement in mRNA vaccine technology with the issue of U.S. Patent 11,596,685 by the United States Patent and Trademark Office (USPTO) on March 7, 2023.